Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNC | P24863 | 1/20 | 0.49 |
| ▸ | CDK8 | P49336 | 1/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 6/20 | 0.48 |
| ▸ | CYP11B1 | P15538 | 6/20 | 0.48 |
| ▸ | CYP11B2 | P19099 | 6/20 | 0.48 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dinitrophenylene SCHEMBL28072310 | 0.83 | L3MBTL1 (0.54) | CYP19A1CYP11B1CYP11B2RIPK1MAPT | |
| SCHEMBL11045904 | 0.79 | POLB (0.67) | CYP19A1MEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL23637665 | 0.78 | CXCR3 (0.56) | CYP19A1MAPTKMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL7669106 | 0.78 | TSHR (0.43) | CCNCCDK8MAPTALDH1A1POLB | |
| SCHEMBL694426 | 0.76 | POLB (0.43) | MEN1MAPTKMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL2768180 | 0.76 | TSHR (0.42) | CCNCCDK8MAPTALDH1A1POLB | |
| SCHEMBL2470383 | 0.76 | TSHR (0.49) | CCNCCDK8MAPTKMT2AALDH1A1 | |
| SCHEMBL2468958 | 0.76 | MAPT (0.45) | MEN1MAPTKMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL1619390 | 0.76 | LOXL2 (0.46) | CCNCCDK8MAPTALDH1A1TSHR | |
| SCHEMBL6747115 | 0.75 | POLB (0.57) | CYP19A1CYP11B1CYP11B2RIPK1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1196590-B1 | PROCESS OF SEPARATION OF EPOXIDE-ENANTIOMER MIXTURES BY EPOXIDE-HYDROLASE PRODUCING MICROORGANISMS | BASF SE (DE) | 2008-07-09 | — | — | EP | claimed |
| US-4826772-A | P-NITROBENZYL PYRIDINE, AMMONIUM CHLORIDE, DEVELOPER | GRAPHIC CONTROLS CANADA, LTD. (CA) | 1989-05-02 | — | — | US | claimed |
| CN-117187148-A | Recombinant escherichia coli producing bacillus epoxide hydrolase as well as construction method and application thereof | 江西师范大学 | 2023-12-08 | — | — | CN | disclosed |
| US-9327033-B2 | Degradation-stabilised, biocompatible collagen matrices | MEDSKIN SOLUTIONS DR. SUWELACK AG (DE) | 2016-05-03 | — | — | US | disclosed |
| EP-2468307-B1 | Degradation-stabilised, biocompatible collagen matrices | MEDSKIN SOLUTIONS DR SUWELACK AG (DE) | 2015-04-22 | — | — | EP | disclosed |
| EP-2789352-A1 | Degradation-stabilised, biocompatible collagen matrices | MedSkin Solutions Dr. Suwelack AG (DE) | 2014-10-15 | — | — | EP | disclosed |
| US-20140287006-A1 | Degradation-Stabilised, Biocompatible Collagen Matrices | MEDSKIN SOLUTIONS DR. SUWELACK AG (DE) | 2014-09-25 | — | — | US | disclosed |
| US-8722854-B2 | Degradation-stabilised, biocompatible collagen matrices | MEDSKIN SOLUTIONS DR. SUWELACK AG (DE) | 2014-05-13 | — | — | US | disclosed |
| US-20120165264-A1 | Degradation-Stabilised, Biocompatible Collagen Matrices | DR. SUWELACK SKIN & HEALTH CARE AG (DE) | 2012-06-28 | — | — | US | disclosed |
| EP-2468307-A1 | Degradation-stabilised, biocompatible collagen matrices | Dr. Suwelack Skin & Health Care AG (DE) | 2012-06-27 | — | — | EP | disclosed |
| EP-1196590-B1 | PROCESS OF SEPARATION OF EPOXIDE-ENANTIOMER MIXTURES BY EPOXIDE-HYDROLASE PRODUCING MICROORGANISMS | BASF SE (DE) | 2008-07-09 | — | — | EP | disclosed |
| US-4419522-A | ANTITUMOR AGENTS | CHINOIN GYOGYSZER VEGYESZETI TERMEKEK GYARA RT. (HU) | 1983-12-06 | — | — | US | disclosed |
| US-4383834-A | IN THE PRESENCE OF A WATER SOLUBLE CATIONIC POLYELECTROLYTE | BASF AKTIENGESELLSCHAFT (DE) | 1983-05-17 | — | — | US | disclosed |
| EP-0061173-A1 | Process for dyeing paper | BASF Aktiengesellschaft (DE) | 1982-09-29 | — | — | EP | disclosed |
| EP-0061169-A1 | Method for the elimination of anionic substances from water | BASF Aktiengesellschaft (DE) | 1982-09-29 | — | — | EP | disclosed |
| EP-0051467-A1 | Hexitol derivatives, their preparation and pharmaceutical compositions containing them | CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. (HU) | 1982-05-12 | — | — | EP | disclosed |
| US-4198433-A | HYDROGEN BROMIDE SALTS OF BIS(2-DICHLOROETHYL)HYDRAZIDES OF CYSTINE AND CYSTEINE | ECNPK PO BIOLOGIA I MEDIKO-BIOLOGICHNI PROBLEMI PRI BAN (BG) | 1980-04-15 | — | — | US | disclosed |
| US-4144123-A | EPICHLOROHYDRIN DERIVATIVE OF POLYETHER AS CROSSLINKER | BASF AKTIENGESELLSCHAFT (DE) | 1979-03-13 | — | — | US | disclosed |
| US-4066494-A | NITROGENOUS CONDENSATION PRODUCTS USED AS RETENTION AIDS IN PAPERMAKING | BASF AKTIENGESELLSCHAFT (DT) | 1978-01-03 | — | — | US | disclosed |
| US-4050895-A | Optical analytical device, waveguide and method | MONSANTO RESEARCH CORPORATION (US) | 1977-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120165264-A1 | Degradation-Stabilised, Biocompatible Collagen Matrices | COL14A1, COL1A1, COL2A1 | CCNC 1631/4885CDK8 4006/4885CYP19A1 1026/4885 |
| US-20140287006-A1 | Degradation-Stabilised, Biocompatible Collagen Matrices | COL14A1, COL1A1, COL2A1 | CCNC 1631/4885CDK8 4006/4885CYP19A1 1026/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.